AzTrials
AzTrials

Elective Primary THA or TKANCT07917533

Is Routine Dental Clearance or Antibiotic Prophylaxis Before Dental Procedures Necessary in Total Joint Arthroplasty? A Randomized Controlled Noninferiority Trial

A study testing Dental Clearance and Routine Antibiotic Prophylaxis in people with Elective Primary THA or TKA, run by Creighton University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a prospective, randomized, controlled, noninferiority trial with parallel assignment that will afford simultaneous assessment of the omission of dental clearance and the omission of post-operative antibiotics for dental procedures. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Elective Primary THA or TKA
What is being tested?
Dental Clearance and Routine Antibiotic Prophylaxis
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,048 participants
Where
No sites listed yet
Study dates
15 Dec 2026to 1 Jul 2032
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥19 years (19 is age of majority in Nebraska)
  • Scheduled for elective primary THA or TKA (i.e. no revision or conversion procedures)
  • Ability to provide informed consent

Who cannot join

  • Revision arthroplasty
  • Arthroplasty for fracture or performed urgently (i.e. incomplete work up)
  • Active or previous infection of the operative joint
  • Active systemic infection
  • On chronic antibiotic therapy
  • All patients who meet the above criteria will be offered inclusion in the study either at their pre-operative clinic visit or over the phone.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

This study is a prospective, randomized, controlled, noninferiority trial with parallel assignment that will afford simultaneous assessment of the omission of dental clearance and the omission of post-operative antibiotics for dental procedures.

Read the detailed description

A noninferiority design is chosen because elimination of a preoperative requirement may offer substantial benefits in cost, access, and timeliness of care; provided infection risk is not meaningfully increased.

Study Questions

  1. Is omission of routine preoperative dental clearance non-inferior to mandatory dental clearance with respect to prosthetic joint infection risk following elective primary hip or knee arthroplasty?
  2. Is omission of routine postoperative antibiotic prophylaxis non-inferior to prescription of routine antibiotic prophylaxis with respect to prosthetic joint infection risk following elective primary hip or knee arthroplasty?
Being tested
Dental Clearance and Routine Antibiotic Prophylaxis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dental Clearance and Routine Antibiotic ProphylaxisOther

    Dental Clearance Group Participants will undergo standardized preoperative dental evaluation. Any dental treatment recommended by the treating dental provider must be completed prior to surgery, with written clearance documented before proceeding.

    No Dental Clearance Group Participants will proceed directly to arthroplasty without mandatory dental evaluation. Acute dental symptoms arising preoperatively will be managed according to standard clinical practice.

    Routine Antibiotic Prophylaxis Group

    Participants will receive antibiotic prophylaxis before every dental procedure, including routine cleanings:

    • Amoxicillin 2 g orally 30-60 minutes prior
    • Clindamycin 600 mg orally for penicillin allergy

    No Antibiotic Prophylaxis Group Participants will receive no routine antibiotic prophylaxis prior to any dental procedure, including cleanings. All other dental care will proceed per standard practice.

Study groups in NCT07917533
Study groupRoleWhat they receive
1. Obtains dental clearance and undergoes routine antibiotic prophylaxisNo intervention1. This is the current standard of care. 2. Dental clearance involves a dental exam. If any abnormalities are noted, then additional procedures are performed at the dentist's discretion before proceeding with hip or knee arthroplasty. 3. Once dental clearance is obtained, then patient proceeds to surgery 4. Post-operatively, the patients receive antibiotic prophylaxis prior to any dental
2. Omits dental clearance and undergoes routine antibiotic prophylaxisExperimental1. Routine dental clearance will be omitted and the patient will proceed to surgery without dental clearance. 2. The joint arthroplasty will otherwise be performed according to the standard practice of the surgeon, already designed to minimize risk to the patient, including risk of PJI. 3. Post-operatively, the patients receive antibiotic prophylaxis prior to any dental procedures/cleanings for a duration of 2 years.
Receives: Other: Dental Clearance and Routine Antibiotic Prophylaxis
3. Obtains dental clearance and omits routine antibiotic prophylaxisExperimental1. Dental clearance involves a dental exam. If any abnormalities are noted, then additional procedures are performed at the dentist's discretion before proceeding with hip or knee arthroplasty. 2. Once dental clearance is obtained, then patient proceeds to surgery 3. Post-operatively, the patient does not receive routine antibiotic prophylaxis before dental procedures.
Receives: Other: Dental Clearance and Routine Antibiotic Prophylaxis
4. Omits dental clearance and routine antibiotic prophylaxisExperimental1. Routine dental clearance will be omitted and the patient will proceed to surgery without dental clearance. 2. The joint arthroplasty will otherwise be performed according to the standard practice of the surgeon, already designed to minimize risk to the patient, including risk of PJI. 3. Post-operatively, the patient does not receive routine antibiotic prophylaxis before dental procedures.
Receives: Other: Dental Clearance and Routine Antibiotic Prophylaxis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Periprosthetic joint infection (PJI) within 12 months, defined using Musculoskeletal Infection Society criteria (Parvizi, et al).

    1. To determine whether omission of routine preoperative dental clearance is non-inferior to mandatory dental clearance in preventing periprosthetic joint infection within 12 months following primary TJA.

    Measured: 12 Months

Secondary outcomes (5)
  1. • Periprosthetic joint infection at 24, 36, 48, 60 and 120 months, defined using Musculoskeletal Infection Society criteria (Parvizi, et al).

    1. To determine whether the omission of dental clearance or omission of routine dental clearance is non-inferior to routine use of these perioperatively at longer term follow up (2, 5 and 10 years).

    Measured: 120 months

  2. • Time from scheduling to surgery (i.e. delay caused by dental clearance)

    1. To compare time from surgical scheduling to operative date.

    Measured: 3-5 years

  3. • Rate of patients requiring dental procedure before getting dental clearance

    1. To determine the rate of dental intervention in patients requiring clearance.

    Measured: 3-5 years

  4. • Number of reoperations and which procedure is performed for PJI.

    1. To compare reoperation and revision arthroplasty rates for infection.

    Measured: 3-5 years

  5. • Causative organisms of PJI

    1. To characterize microbiologic profiles of PJIs.

    Measured: 3-5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2026
  2. Study start15 Dec 2026 (estimated)
  3. Primary completion1 Jan 2031 (estimated)
  4. Study completion1 Jul 2032 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
3,048 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07917533
Sponsor's protocol ID
CommonSpirit IRB 2447281-1
Status last verified
Oct 2026
First submitted
29 Oct 2026
Last updated
4 Nov 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Results will otherwise be disseminated through academic journals as well as poster or podium presentations at academic meetings.

Questions about this trial

What is this clinical trial studying?

A study testing Dental Clearance and Routine Antibiotic Prophylaxis in people with Elective Primary THA or TKA, run by Creighton University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact John Green, MD (402-717-0820, JohnGreen1@creighton.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Periprosthetic joint infection (PJI) within 12 months, defined using Musculoskeletal Infection Society criteria (Parvizi, et al). (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in